ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
González R, Ataíde R, Naniche D, Menéndez C, Mayor A, 2012. HIV and malaria interactions: where do we stand? Expert Rev Anti Infect Ther 10: 153–165.
-
2.
Rocha A, de Meneses AC, da Silva AM, Ferreira MS, Nishioka SA, Burgarelli MK, Almeida E, Turcato Júnior G, Metze K, Lopes ER, 1994. Pathology of patients with Chagas disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50: 261–268.
-
3.
Morgado MG, Barcellos C, Pina MF, Bastos FI, 2000. Human immunodeficiency virus/acquired immunodeficiency syndrome and tropical diseases: a Brazilian perspective. Mem Inst Oswaldo Cruz 95: 145–151.
-
4.
Karp CL, Auwaerter PG, 2007. Coinfection with HIV and tropical diseases. II. Helminthic, fungal, bacterial, and viral pathogens. Clin Infect Dis 45: 1214–1220.
-
5.
Baggio-Zappia GL, Hernandes GCF, 2009. HIV-GB virus C co-infection: an overview. Clin Chem Lab Med 47: 12–19.
-
6.
Watt G, Kantipong P, Jongsakul K, 2003. Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin Infect Dis 36: 1067–1069.
-
7.
Xiang J, McLinden JH, Rydze RA, Chang Q, Kaufman TM, Klinzman D, Stapleton JT, 2009. Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells. J Immunol 183: 7860–7869.
-
8.
Gonzalez D, Limonta D, Bandera JF, Perez J, Kouri G, Guzman MG, 2009. Dual infection with dengue virus 3 and human immunodeficiency virus 1 in Havana, Cuba. J Infect Dev Ctries 3: 318–320.
-
9.
Siong WC, Ching TH, Jong GC, Pang CS, Vernon LJ, Sin LY, 2008. Dengue infections in HIV patients. Southeast Asian J Trop Med Public Health 39: 260–265.
-
10.
Mendes Wda S, Branco Mdos R, Medeiros MN, 2006. Clinical case report: dengue hemorrhagic fever in a patient with acquired immunodeficiency syndrome. Am J Trop Med Hyg 74: 905–907.
-
11.
Delgado-Enciso I, Espinoza-Gómez F, Ochoa-Jiménez R, Valle-Reyes S, Vásquez C, López-Lemus UA, 2016. Dengue infection in a human immunodeficiency virus-1 positive patient chronically infected with hepatitis B virus in western Mexico. Am J Trop Med Hyg 96: 122–125.
-
12.
Pang J, Thein TL, Lye DC, Leo YS, 2015. Differential clinical outcome of dengue infection among patients with and without HIV infection: a matched case-control study. Am J Trop Med Hyg 92: 1156–1162.
-
13.
Torrentes-Carvalho A, Hottz ED, Marinho CF, da Silva JB, de Oliveira Pinto LM, Fialho LG, Bozza FA, Cunha RV, Damasco PV, Kubelka CF, de Azeredo EL, 2016. Characterization of clinical and immunological features in patients coinfected with dengue virus and HIV. Clin Immunol 164: 95–105.
-
14.
Ayers M, Adachi D, Johnson G, Andonova M, Drebot M, Tellier R, 2006. A single tube RT-PCR assay for the detection of mosquito-borne flaviviruses. J Virol Methods 135: 235–239.
-
15.
Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ, 2004. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS 18: 1169–1177.
-
16.
Malavige GN, Huang LC, Salimi M, Gomes L, Jayaratne SD, Ogg GS, 2012. Cellular and cytokine correlates of severe dengue infection. PLoS One 7: e50387.
-
17.
Perez-Ramirez G, Diaz-Badillo A, Camacho-Nuez M, Cisneros A, Munoz M de L, 2009. Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico. BMC Microbiol 9: 260.
-
18.
López-Lemus UA, Vásquez C, Vázquez-Campuzano R, Valle-Reyes S, Guzmán-Bracho C, Araiza-Garaygordobil D, Rebolledo-Prudencio N, Delgado-Enciso I, Espinoza-Gómez F, 2014. Dengue virus serotype 1 non-structural protein NS5 expression interferes with HIV replication in a CD4+ T-cell line. Am J Trop Med Hyg 90: 418–421.
-
19.
McLinden JH, Stapleton JT, Chang Q, Xiang J, 2008. Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication. J Infect Dis 198: 860–863.
-
20.
Chang Q, McLinden JH, Stapleton JT, Aslam SM, Xiang J, 2007. Expression of GB virus C NS5A protein from genotypes 1, 2, 3 and 5 and a 30 aa NS5A fragment inhibit human immunodeficiency virus type 1 replication in a CD4+ T-lymphocyte cell line. J Gen Virol 88: 3341–3346.
-
21.
Xiang J, McLinden JH, Chang Q, Kaufman TM, Stapleton JT, 2006. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci USA 103: 15570–15575.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 557 | 480 | 7 |
| Full Text Views | 259 | 11 | 0 |
| PDF Downloads | 89 | 14 | 0 |
Dengue Virus Coinfection in Human Immunodeficiency Virus-1-Infected Patients on the West Coast of Mexico
Francisco Espinoza-Gómez
Francisco Espinoza-Gómez
Department of Internal Medicine, University Regional Hospital, Ministry of Health, Colima, Mexico;
School of Medicine, University of Colima, Colima, Mexico;
Search for other papers by Francisco Espinoza-Gómez in
Current site
Google Scholar
PubMed
School of Medicine, University of Colima, Colima, Mexico;
Search for other papers by Francisco Espinoza-Gómez in
Current site
Google Scholar
PubMed
Iván Delgado-Enciso
Iván Delgado-Enciso
School of Medicine, University of Colima, Colima, Mexico;
Cancer State Institute, Ministry of Health, Colima, Mexico;
Search for other papers by Iván Delgado-Enciso in
Current site
Google Scholar
PubMed
Cancer State Institute, Ministry of Health, Colima, Mexico;
Search for other papers by Iván Delgado-Enciso in
Current site
Google Scholar
PubMed
Salvador Valle-Reyes
Salvador Valle-Reyes
School of Medicine, University of Colima, Colima, Mexico;
Search for other papers by Salvador Valle-Reyes in
Current site
Google Scholar
PubMed
Search for other papers by Salvador Valle-Reyes in
Current site
Google Scholar
PubMed
Rodolfo Ochoa-Jiménez
Rodolfo Ochoa-Jiménez
Department of Internal Medicine, University Regional Hospital, Ministry of Health, Colima, Mexico;
Search for other papers by Rodolfo Ochoa-Jiménez in
Current site
Google Scholar
PubMed
Search for other papers by Rodolfo Ochoa-Jiménez in
Current site
Google Scholar
PubMed
Conrado Arechiga-Ramírez
Conrado Arechiga-Ramírez
Department of Internal Medicine, University Regional Hospital, Ministry of Health, Colima, Mexico;
Search for other papers by Conrado Arechiga-Ramírez in
Current site
Google Scholar
PubMed
Search for other papers by Conrado Arechiga-Ramírez in
Current site
Google Scholar
PubMed
José L. Gámez-Arroyo
José L. Gámez-Arroyo
Department of Internal Medicine, University Regional Hospital, Ministry of Health, Colima, Mexico;
Search for other papers by José L. Gámez-Arroyo in
Current site
Google Scholar
PubMed
Search for other papers by José L. Gámez-Arroyo in
Current site
Google Scholar
PubMed
Roberto Vázquez-Campuzano
Roberto Vázquez-Campuzano
Department of Emerging Diseases and Emergencies, Institute for Epidemiological Diagnosis and Reference, Ministry of Health, Mexico City, Mexico;
Search for other papers by Roberto Vázquez-Campuzano in
Current site
Google Scholar
PubMed
Search for other papers by Roberto Vázquez-Campuzano in
Current site
Google Scholar
PubMed
Carmen Guzmán-Bracho
Carmen Guzmán-Bracho
Department of Emerging Diseases and Emergencies, Institute for Epidemiological Diagnosis and Reference, Ministry of Health, Mexico City, Mexico;
Search for other papers by Carmen Guzmán-Bracho in
Current site
Google Scholar
PubMed
Search for other papers by Carmen Guzmán-Bracho in
Current site
Google Scholar
PubMed
Clemente Vásquez
Clemente Vásquez
School of Medicine, University of Colima, Colima, Mexico;
Search for other papers by Clemente Vásquez in
Current site
Google Scholar
PubMed
Search for other papers by Clemente Vásquez in
Current site
Google Scholar
PubMed
Uriel A. López-Lemus
Uriel A. López-Lemus
School of Medicine, University of Colima, Colima, Mexico;
Center for Gene Therapy, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope, Duarte, California
Search for other papers by Uriel A. López-Lemus in
Current site
Google Scholar
PubMed
Center for Gene Therapy, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope, Duarte, California
Search for other papers by Uriel A. López-Lemus in
Current site
Google Scholar
PubMed
Dengue virus infection in human immunodeficiency virus (HIV)-positive patients is not well studied. Previous reports suggest a transitory inhibition of the HIV-1 viral load, as well as a benign clinical progression of dengue. The follow-up of six HIV-1-infected patients, diagnosed and hospitalized with dengue virus infection in the State of Colima, Mexico, was carried out to analyze the progression of this viral coinfection. The presence of dengue virus serotype 1 was confirmed through molecular tests. No severe complications were observed in any of the patients during dengue virus infection. Significant alteration of the HIV-1 viral loads was not observed during dengue virus infection and 6 months after coinfection. Further studies are required to understand the pathology, as well as the clinical course, of these viral coinfections.
Author Notes
Authors’ addresses: Francisco Espinoza-Gómez and Iván Delgado-Enciso, Department of Public Health, University of Colima, Colima, Mexico, E-mails: fespin@ucol.mx and ivan_delgado_enciso@ucol.mx. Salvador Valle-Reyes, Rodolfo Ochoa-Jiménez, and Uriel A. López-Lemus, Department of Public Health, University of Colima, School of Medicine, Colima, Mexico, E-mails: juanchavador@hotmail.com, docochoa@hotmail.com, and lemus_a83@yahoo.com. Conrado Arechiga-Ramírez and José L. Gámez-Arroyo, Hospital Regional Universitario de Colima, Internal Medicine, Colima, Mexico, E-mails: drpepearechiga@latinmail.com and gamezajl@hotmail.com. Roberto Vázquez-Campuzano and Carmen Guzmán-Bracho, Department of Emerging Diseases and Emergencies, Institute for Epidemiological Diagnosis and Reference, Mexico City, Mexico, E-mails: roberto.vazquez@salud.gob.mx and carmen.guzman@salud.gob.mx. Clemente Vásquez, Department of Biomedical Sciences, University of Colima, Colima, Mexico, E-mail: clemvas@ucol.mx.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
González R, Ataíde R, Naniche D, Menéndez C, Mayor A, 2012. HIV and malaria interactions: where do we stand? Expert Rev Anti Infect Ther 10: 153–165.
-
2.
Rocha A, de Meneses AC, da Silva AM, Ferreira MS, Nishioka SA, Burgarelli MK, Almeida E, Turcato Júnior G, Metze K, Lopes ER, 1994. Pathology of patients with Chagas disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50: 261–268.
-
3.
Morgado MG, Barcellos C, Pina MF, Bastos FI, 2000. Human immunodeficiency virus/acquired immunodeficiency syndrome and tropical diseases: a Brazilian perspective. Mem Inst Oswaldo Cruz 95: 145–151.
-
4.
Karp CL, Auwaerter PG, 2007. Coinfection with HIV and tropical diseases. II. Helminthic, fungal, bacterial, and viral pathogens. Clin Infect Dis 45: 1214–1220.
-
5.
Baggio-Zappia GL, Hernandes GCF, 2009. HIV-GB virus C co-infection: an overview. Clin Chem Lab Med 47: 12–19.
-
6.
Watt G, Kantipong P, Jongsakul K, 2003. Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin Infect Dis 36: 1067–1069.
-
7.
Xiang J, McLinden JH, Rydze RA, Chang Q, Kaufman TM, Klinzman D, Stapleton JT, 2009. Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells. J Immunol 183: 7860–7869.
-
8.
Gonzalez D, Limonta D, Bandera JF, Perez J, Kouri G, Guzman MG, 2009. Dual infection with dengue virus 3 and human immunodeficiency virus 1 in Havana, Cuba. J Infect Dev Ctries 3: 318–320.
-
9.
Siong WC, Ching TH, Jong GC, Pang CS, Vernon LJ, Sin LY, 2008. Dengue infections in HIV patients. Southeast Asian J Trop Med Public Health 39: 260–265.
-
10.
Mendes Wda S, Branco Mdos R, Medeiros MN, 2006. Clinical case report: dengue hemorrhagic fever in a patient with acquired immunodeficiency syndrome. Am J Trop Med Hyg 74: 905–907.
-
11.
Delgado-Enciso I, Espinoza-Gómez F, Ochoa-Jiménez R, Valle-Reyes S, Vásquez C, López-Lemus UA, 2016. Dengue infection in a human immunodeficiency virus-1 positive patient chronically infected with hepatitis B virus in western Mexico. Am J Trop Med Hyg 96: 122–125.
-
12.
Pang J, Thein TL, Lye DC, Leo YS, 2015. Differential clinical outcome of dengue infection among patients with and without HIV infection: a matched case-control study. Am J Trop Med Hyg 92: 1156–1162.
-
13.
Torrentes-Carvalho A, Hottz ED, Marinho CF, da Silva JB, de Oliveira Pinto LM, Fialho LG, Bozza FA, Cunha RV, Damasco PV, Kubelka CF, de Azeredo EL, 2016. Characterization of clinical and immunological features in patients coinfected with dengue virus and HIV. Clin Immunol 164: 95–105.
-
14.
Ayers M, Adachi D, Johnson G, Andonova M, Drebot M, Tellier R, 2006. A single tube RT-PCR assay for the detection of mosquito-borne flaviviruses. J Virol Methods 135: 235–239.
-
15.
Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ, 2004. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS 18: 1169–1177.
-
16.
Malavige GN, Huang LC, Salimi M, Gomes L, Jayaratne SD, Ogg GS, 2012. Cellular and cytokine correlates of severe dengue infection. PLoS One 7: e50387.
-
17.
Perez-Ramirez G, Diaz-Badillo A, Camacho-Nuez M, Cisneros A, Munoz M de L, 2009. Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico. BMC Microbiol 9: 260.
-
18.
López-Lemus UA, Vásquez C, Vázquez-Campuzano R, Valle-Reyes S, Guzmán-Bracho C, Araiza-Garaygordobil D, Rebolledo-Prudencio N, Delgado-Enciso I, Espinoza-Gómez F, 2014. Dengue virus serotype 1 non-structural protein NS5 expression interferes with HIV replication in a CD4+ T-cell line. Am J Trop Med Hyg 90: 418–421.
-
19.
McLinden JH, Stapleton JT, Chang Q, Xiang J, 2008. Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication. J Infect Dis 198: 860–863.
-
20.
Chang Q, McLinden JH, Stapleton JT, Aslam SM, Xiang J, 2007. Expression of GB virus C NS5A protein from genotypes 1, 2, 3 and 5 and a 30 aa NS5A fragment inhibit human immunodeficiency virus type 1 replication in a CD4+ T-lymphocyte cell line. J Gen Virol 88: 3341–3346.
-
21.
Xiang J, McLinden JH, Chang Q, Kaufman TM, Stapleton JT, 2006. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci USA 103: 15570–15575.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 557 | 480 | 7 |
| Full Text Views | 259 | 11 | 0 |
| PDF Downloads | 89 | 14 | 0 |